DAFNA Capital Management LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$11,117,000
+56.1%
119,6150.0%2.80%
+47.9%
Q3 2021$7,123,000
-12.7%
119,6150.0%1.89%
+10.8%
Q2 2021$8,158,000
+53.3%
119,615
+55.9%
1.71%
+35.1%
Q1 2021$5,323,000
-9.8%
76,715
-0.1%
1.26%
-28.1%
Q4 2020$5,902,000
+4.1%
76,815
+1.3%
1.76%
-4.7%
Q3 2020$5,670,000
-63.3%
75,815
-69.1%
1.84%
-58.6%
Q2 2020$15,432,000
+104.5%
245,142
+36.5%
4.45%
+41.4%
Q1 2020$7,545,000
+67.9%
179,642
+81.6%
3.15%
+104.1%
Q4 2019$4,494,000
+4.5%
98,942
+5.3%
1.54%
-4.6%
Q3 2019$4,300,000
-21.9%
93,9420.0%1.62%
-21.9%
Q2 2019$5,508,000
+30.8%
93,9420.0%2.07%
+13.9%
Q1 2019$4,211,000
+15.1%
93,9420.0%1.82%
-0.2%
Q4 2018$3,659,000
-19.3%
93,942
-4.7%
1.82%
-2.3%
Q3 2018$4,535,000
+9.2%
98,547
+3.5%
1.86%
-4.2%
Q2 2018$4,153,000
-17.0%
95,242
-24.9%
1.94%
-20.2%
Q1 2018$5,006,000
+1810.7%
126,742
+715.1%
2.44%
+1202.1%
Q2 2017$262,00015,5500.19%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 4,190,000$321,918,0005.54%
Prosight Management, LP 145,700$11,194,0005.17%
Integral Health Asset Management, LLC 200,000$15,366,0004.57%
Copernicus Capital Management, LLC 3,740$287,0004.47%
GREAT POINT PARTNERS LLC 345,120$26,516,0004.31%
Asymmetry Capital Management, L.P. 101,245$7,779,0003.55%
First Light Asset Management, LLC 321,967$24,737,0001.83%
DAFNA Capital Management LLC 76,815$5,902,0001.76%
SECTORAL ASSET MANAGEMENT INC 320,059$24,590,0001.73%
Nicholas Investment Partners, LP 276,633$21,254,0001.64%
View complete list of ARENA PHARMACEUTICALS INC shareholders